VECTOR STRATEGIC ADVISORS LLC
Vector Strategic Advisors is a licensing and commercial strategy advisory firm founded in 2010 by Patricia Sinatra. The company specializes in licensing strategy, market analytics, and commercial assessments for early-stage to mid-sized biopharmaceutical companies and universities. They focus on providing external validation, market positioning, and strategic licensing advice, with expertise across various therapeutic areas and technology platforms. Their approach emphasizes differentiability, market potential, and intellectual property strength to facilitate licensing, M&A, or IPO activities.
Industries
Nr. of Employees
small (1-50)
VECTOR STRATEGIC ADVISORS LLC
San Francisco, California, United States, North America
Services
Consulting support for preparing materials, identifying partners, outreach, representing clients in partnering meetings, and negotiating term sheets and definitive agreements for out-licensing transactions.
Sourcing and evaluation of in-licensing opportunities, representation in partnering discussions, term negotiation and due diligence coordination for acquiring assets or technologies.
Primary and secondary market research, competitive landscape analysis, forecast modeling, and target profile validation to support licensing and commercialization decisions.
Support for structuring transactions, negotiating term sheets and definitive agreements, and coordinating due diligence activities between parties.
Custom in-house business development instruction, participation in industry business development courses, and mentoring for entrepreneurship programs.
Development of fundraising approaches and outreach to potential investors or strategic partners to support company financing and transaction objectives.
Consulting support for preparing materials, identifying partners, outreach, representing clients in partnering meetings, and negotiating term sheets and definitive agreements for out-licensing transactions.
Sourcing and evaluation of in-licensing opportunities, representation in partnering discussions, term negotiation and due diligence coordination for acquiring assets or technologies.
Primary and secondary market research, competitive landscape analysis, forecast modeling, and target profile validation to support licensing and commercialization decisions.
Support for structuring transactions, negotiating term sheets and definitive agreements, and coordinating due diligence activities between parties.
Custom in-house business development instruction, participation in industry business development courses, and mentoring for entrepreneurship programs.
Development of fundraising approaches and outreach to potential investors or strategic partners to support company financing and transaction objectives.
Expertise Areas
- Licensing and alliance management
- Commercial strategy and market positioning
- Market research and forecasting
- Business development and fundraising strategy
Key Technologies
- Antibody platforms
- Antibody-drug conjugates (ADC)
- Fully human antibody engineering
- Targeted small-molecule therapeutics